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Abstract: Epitopes are essential peptides for immune system stimulation, such as governing helper T 
lymphocyte (HTL) activation via antigen presentation and recognition. Current predictive models for epitope 
selection mainly rely on the antigen presentation, although HTLs only recognize 50% of the presented peptides. 
Thus, we developed a HTL epitope predictor which involves the antigen recognition step. The predictor is 
specific for epitopes presented by Human Leukocyte Allele (HLA)-DRB1*01:01, which is protective against 
developing multiple sclerosis and association with autoimmune diseases. As the data set, we used binding 
register of immunogenic and non-immunogenic HTL peptides related to HLA-DRB1*01:01. The binding 
registers were obtained from consensus results of two current HLA-binder predictors. Amino acid descriptors 
were extracted from the binding registers and subjected to random forest algorithm. A threshold optimization 
were applied to overcome data set imbalance class. In addition, descriptors were screened by using a recursive 
feature elimination to enhance the model performance. The obtained model shows that the hydrophobicity, 
steric, and electrostatic properties of epitopes, mainly at center of binding registers, are important for the TCR 
recognition as well as the HTL epitopes predictive model. The model complements current HLA-DRB1*01:01-
binder prediction methods to screen immunogenic HTL epitopes. 
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Abstrak: Epitop adalah peptida yang sangat penting dalam stimulasi sistem kekebalan, seperti dalam 
pengaturan aktivasi limfosit T penolong (HTL) melalui presentasi dan pengenalan antigen. Saat ini, model 
prediksi untuk menyeleksi epitop hanya berdasarkan pada presentasi antigen, meskipun HTL hanya mengenali 
50% peptida yang dipresentasikan. Maka, kami mengembangkan model prediksi yang melibatkan tahapan 
pengenalan antigen. Model prediksi yang dikembangkan spesifik untuk epitop yang dipresentasikan oleh Human 
Leukocyte Allele (HLA)-DRB1*01:01, yang bersifat proteksi terhadap sklerosis ganda dan berkaitan dengan 
penyakit-penyakit autoimun. Sisi pengikatan peptida HTL yang imunogenik dan non-imunogenik pada HLA-
DRB1*01:01 digunakan sebagai data set. Informasi sisi pengikatan diperoleh dari hasil konsensus dua server 
prediksi peptida. Selanjuntya, deskriptor asam amino diekstrak dari sisi pengikatan peptida dan digunakan 
untuk melatih model algoritma random forest. Pendekatan optimasi ambang juga digunakan untuk mengatasi 
ketidakseimbangan jumlah kelas pada data set. Selain itu, deskriptor diseleksi dengan metode eliminasi rekursif 
untuk meningkatkan performa model. Model yang dihasilkan menunjukkan bahwa hidrofobisitas, sterik, dan 
elektrostatik epitop, terutama pada bagian sisi pengikatan peptida ke MHC, penting bagi pengenalan TCR. 
Model prediksi ini melengkapi metode prediksi peptida yang terikat pada HLA-DRB1*01:01 untuk menyeleksi 
epitop HTL yang imunogenik. 
 
Kata kunci: epitop, model prediktif, helper T lymphocyte, algoritma random forest 
 
INTRODUCTION  
In human, the adaptive immune system has an 
essential role in protecting hosts from diverse 
pathogen invasions. Through CD8+ cytotoxic T 
lymphocytes (CTLs), it destroys either infected or 
tumor cells. Meanwhile, activating CD4+ helper T 
lymphocytes (HTL) provokes other immune cells like 
B cells and macrophages to eventually destroy 
pathogens (Murphy 2011). These responses are relied 
on two important molecular events. The first event is 
the antigen presentation, where the antigenic peptide 
epitope binds to the major histocompatibility 
complex (MHC) as pMHC. The second event is the T 
cell receptor (TR) recognition of pMHC which 
results in the activation of either CTL or HTL (Khan 
& Ranganathan 2011). 
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CTLs and HTLs recognize dissimilar peptide 
epitopes displayed by two different MHC molecules 
(Murphy 2011). MHC class I molecules load peptide 
epitopes (CTL epitopes) for CTL recognition, 
whereas MHC class II molecules present other kinds 
of peptide epitopes (HTL epitopes) for HTL. CTL 
epitopes, possessing length 9-11 residues, are 
intracellular pathogens origin. They particularly bind 
the MHC class I through their N- and C-termini 
residues, as the consequence their middle parts have a 
bulged conformation. On the other hand, HTL 
epitopes are generated through a serial antigen 
processing of extracellular pathogens and have length 
12-25 residues. They use their nine sequential amino 
acids to bind MHC class II. These nine residues, 
which are called peptide binding registers, mainly 
interact with the MHC class II at positions 1, 4, 6, 
and 9 (Sant’Angelo et al. 2002). The rest residues of 
HTL epitopes, referred as peptide flanking residues 
or PFRs, can extend outside N- and C-termini of the 
groove.   
Peptide epitope sequences are vital information to 
develop vaccines in prophylactic and 
immunotherapeutic settings. Such information 
assisted the development of the next-generation 
Malaria RTS,S vaccine (MosquirixTM) which 
acquired a final recommendation from WHO in 2015 
(Oyarzún & Kobe 2016). Interestingly, peptide 
epitope information also contributed to the 
development of the RNA-lipoplex vaccine targeting 
melanoma which reached a phase I clinical trial in 
2016 (Gilboa 2016).  
Unfortunately, peptide epitope discovery through 
experimental methods are laborious, time consuming, 
and costly (Tong et al. 2007).  To address such 
problems, many research groups worldwide have 
developed computational approaches (i.e. 
immunoinformatics’) either using structure- (Rognan 
et al. 1994; Rosenfeld et al. 1995; Tong et al. 2004; 
Bordner & Abagyan 2006; Khan & Ranganathan 
2010; Patronov et al. 2011) or sequence-based  
approaches (Rammensee et al. 1999; Guan et al. 
2003; Reche et al. 2004; Zhang et al. 2005; Nielsen 
et al. 2004; Gonzalez-Galarza et al. 2011; Zhang et 
al. 2012; Karosiene et al. 2013; Andreatta et al. 
2015). These two methods complement each other, 
where the structural approach needs sequences and 
vice versa. Both approaches construct their 
algorithms based on the binding of the peptide 
epitope to the MHC, because this antigen 
presentation event is considered as the critical step in 
the immune system activation. Most methods assume 
that the higher binding affinity values of MHC-bound 
peptides are, the longer time they are presented. 
Hence, they have a bigger change to be recognized 
by T cell. Studies revealed that only a half of such 
peptide MHC-binders are recognized by T cells or 
immunogenic (Chuan & Ranganathan 2013), 
however.  
In last a decade, some groups started to develop 
immunogenicity prediction methods for CTL 
epitopes related to HLA-A2. The first predictor was 
POPI. It used 23 physicochemical properties and feed 
them to a super vector machine (SVM) classifier. The 
same group then developed a POPISK using SVM 
with string kernels (Tung et al. 2011). It 
outperformed POPI and identified six important 
positions (1, 4, 5, 6, 8, and 9) for CTL epitopes 
immunogenicity. Another group, Saethang et al. 
(2013), built a PAAQD using a random forest based 
on amino acid pairwise contact potentials (AAPP) 
and quantum topological molecular similarity 
(QTMS) descriptors. They suggested that the 
positions 1 and 8 determine the immunogenicity of 
nonamer peptide epitopes, whereas the anchor 
residues less contribute in T-cell reactivity prediction. 
Chowell et al. (2015) analyzed a hydrophobicity 
difference between immunogenic and non-
immunogenic CTL peptides. They found that the 
hydrophobicity property is sufficient to predict 
immunogenic CTL epitopes. Zhang et al. (2015) 
applied genetic algorithm-based ensemble learning, 
as a feature selection, on various combination of 
physicochemical descriptors. They proposed that 
relative accessible surface areas (RASA) of peptides 
and AAPP are the optimal features for CTL epitopes 
immunogenicity.  
On the other hand, none of method for HTL 
epitopes immunogenicity is available yet. The 
complexity of HTL epitopes, which consist of 
binding registers and PFRs, is the major challenge in 
their immunogenicity modeling. Intriguingly, these 
peptide epitopes mainly interact with TRs through 
their binding registers (Sant’Angelo et al. 2002). This 
basis could be sufficient for discriminating 
immunogenic HTL epitopes from MHC class II-
binder peptides predicted by current prediction 
servers.  
The HLA-DRB1*01:01 is a kind of human MHC 
class II allele. It is protective against developing 
multiple sclerosis and association with autoimmune 
diseases, for example rheumatoid arthritis (Sauer et 
al. 2015) and Crohn's disease (Goyette et al. 2015). 
Incidence and prevalence of these autoimmune 
diseases worldwide is increasing (Lerner et al. 2015). 
During 2000 to 2016, the number of 583,694 people 
worldwide were suffering multiple sclerosis, and 
108,907 of them reside in the lower middle-income 
region, including Indonesia. Furthermore, in the same 
period of time, around 5 million people in the world 
live with rheumatoid arthritis (WHO 2016). Thus, 
modelling immunogenic HTL epitopes related to 
HLA-DRB1*01:01 is important.  
Despite limited experimental data providing 
binding register information of HTL epitopes, the 
NetMHCIIpan (Andreatta et al. 2015) and the 
TEPITOPEpan (Zhang et al. 2012) exhibited a 
reliable prediction of human MHC class II-bound 
peptides, including the HLA-DRB1*01:01 (Andreatta 
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et al. 2015). Hence, we constructed a data set using 
the consensus result from NetMHCIIpan and 
TEPITOPEpan. The data set contains binding 
registers information of immunogenic and non-
immunogenic HTL peptides related to HLA-
DRB1*01:01. From these binding registers, we 
extracted various amino acid descriptor sets widely 
used in proteochemometric modelling (van Westen et 
al. 2013). We found that VHSE descriptor set is 
representative for immunogenicity modelling. A class 
imbalance, however, was the issue in the data set. It 
causes the resulted prediction model classifying 
unseen data as the majority class member (Kuhn & 
Johnson 2013). Since the model possesses a 
satisfactory area under ROC curve, we carried out 
automatic threshold probability optimization to 
minimize difference between specificity and 
sensitivity. This optimization adjusts automatically 
both in training set and future data. Ultimately, we 
have developed a random forest model of 
immunogenic HTL epitopes presented by HLA-
DRB1*01:01. The model complements the available 
peptides MHC class II-binder prediction servers to 
generate more accurate immunogenic HTL epitopes, 
which further help the development of 
immunotherapies for HLA-DRB1*01:01-related 
diseases, such as multiple sclerosis, Crohn’s disease, 
and rheumatoid arthritis. 
 
MATERIALS AND METHODS 
Data Set Preparation  
Data of HLA-DRB1*01:01-related peptides 
complemented with T cell assays information were 
obtained from IEDB (http://www.iedb.org/) (Vita et 
al. 2018). We removed peptides with unnatural 
amino acids and duplicates. Similarly, we discarded 
peptides possessing both positive and negative result 
of T cell assays. Because of the absence of 
information whether peptides with negative results of 
T cell assays are MHC-binders, we predicted their 
IC50 by using NetMHCIIpan (Andreatta et al. 2015). 
Those peptides with IC50 greater than 500 nM were 
cut off (Karosiene et al. 2013; Peters et al. 2006) to 
make the data set MHC-binder exclusive. Peptide 
binding registers were predicted using NetMHCIIpan 
(Andreatta et al. 2015) and TEPITOPEpan (Zhang et 
al. 2012). Consensus result from both prediction 
servers was collected to yield a binding register data 
set of 392 immunogenic and 122 non-immunogenic T 
cell peptides related to HLA-DRB1*01:01. We then 
randomly split the data set into a training and test set. 
Amino acid descriptors of Vectors of 
Hydrophobicity, Steric and Electronic (VHSE) (Mei 
et al. 2005) were extracted from binding registers 
using a script written in R programming language (R 
Core Team 2015). 
 
Random Forest 
We utilized a random forest algorithm, an 
ensemble of decision trees (Breiman 2001), to train 
immunogenic HTL epitopes model. Let   is 
descriptor vectors with outcome  or a binary label 
of a peptide immunogenicity in n samples of a 
training data, . The 
training data are drawn randomly from a probability 
distribution  to generate a random 
vector of descriptors  , which is independent of the 
previous ones  . The training data and 
 are used to construct a classifier h(x, Θk) of the 
kth tree. The resulted trees vote for the most popular 
class at input x. Implementation of random forest in a 
caret package denotes the  as a tuning parameter 
mtry.  
 
The Iterative Ten-Fold Cross-Validation  
We performed a resampling technique, a ten-
repeated ten-fold cross-validation (Kuhn & Johnson 
2013), for estimating model performance. It 
randomly divided training set into ten subsets. The 
first subset was held-out, while the rest subsets fitted 
a model. The held-out samples were predicted by this 
model and used to estimate performance measures. 
The first subset was returned to the training set and 
the procedure repeated until the last subset. 
    
Collinearity Removal 
We removed collinearity within descriptors using 
a procedure as described in (Kuhn & Johnson 2013). 
The procedure, firstly, calculated correlation matrix 
of the predictors and determined two predictors 
associated with the largest absolute pairwise 
correlation. It then determined the average correlation 
between the first predictor and the other variables and 
did so for the second predictor. It discarded the 
predictor with a larger average correlation, either the 
first or second predictor. The algorithm iteratively 
run the steps above until no absolute correlations 
greater than a threshold of 0.750. 
 
Recursive Feature Elimination with Resampling 
We carried out recursive feature elimination, 
implemented in the caret package (Kuhn 2008; Kuhn 
et al. 2016), as described by Kuhn & Johnson (2013). 
Data were partitioned into first subset and held-back 
set via resampling of 10-fold cross-validation. A 
model was trained using all descriptors on the subset 
set. The hold-back samples were predicted using the 
model and descriptors were ranked according their 
importance. Another models was trained using 
individual descriptor and then used to predict the 
held-back samples. The ranking of each descriptor 
was recalculated. The processes were repeated for all 
subset. The performance profile of descriptors was 
calculated. The number of predictors were 
determined and the final list of descriptors was 
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estimated. The final model was then fitted based on 
the optimal descriptors. 
 
Filter Method for Feature Selection 
As described in (Kuhn et al. 2016), the algorithm 
used univariate statistical methods to filter descriptor 
variables in each iteration. It estimated the 
performance using resampling. In the next step, it 
applied the same filter and the model to entire 
training data. It saved the model and the current 
selected descriptors. The final descriptors were voted 
based on the optimal performance.  
 
Threshold Probability Optimization 
The optimization of threshold probability was 
carried out as described in (Kuhn & Johnson 2013; 
Kuhn et al. 2016). Firstly, a tuning grid searched the 
number of randomly selected predictors, the mtry. 
Using a fix mtry, the training data fitted a single 
random forest model. Next, the algorithm looped 
over the threshold values to obtain prediction from 
the same random forest model. It then fitted the 
model independent of the threshold parameter. To 
evaluate data across thresholds, it created multiple 
versions of the probabilities. Using the current 
candidate value of the probability threshold, it use the 
area under the ROC curve and the sensitivity and 
specificity values. At the end, it selected the 
threshold where the distance between sensitivity and 
specificity is minimum.  
 
Averaging Probabilities  
We randomly split immunogenic data in the 
training set into three partitions. Into each partition, 
we added all non-immunogenic in the training set. 
These steps generated three sub-groups of training set 
where each sub-group has different immunogenic 
data but same non-immunogenic ones. The sub-
groups then trained different random forest learners 
to yield three models of HTL immunogenicity. Each 
model was applied on the test set and resulted in 
immunogenicity probabilities. We then averaged 
probabilities outcome from each test set data point. 
The final class follow the average result. 
 
Position-Based Amino Acid VHSE Descriptors 
Analysis 
We transformed amino acids at peptide binding 
registers into the VHSE descriptor set using R 
statistical software (R Core Team 2015). Next, we 
calculated and plotted the mean descriptors at each 
binding register residue between immunogenic and 
non-immunogenic peptides. In addition, we 
performed a Wilcoxon rank-sum test to position-
based residues of between immunogenic and non-
immunogenic peptides at their binding registers for 
each descriptor element.   
 
 
 
Performance Metrics 
Here we adopted some metrics to the model 
performance. They are an area under ROC curve 
(ROC), sensitivity or recall, specificity, positive 
prediction value (PPV) or precision, Mattew’s 
correlation coefficient (MCC), Kappa, harmonic 
mean of precision and recall (F1), and. These metrics 
are defined as follows: 
 
  
 
 
 
 
 
 
 
 
 
 
  
 Where TP is true positive, FN is false negative, TN 
is true negative, and FP is false positive. The ROC 
curve is obtained by plotting the false positive rate 
(1-specificity) against the sensitivity. The O 
constructing a Kappa metric is the observed 
accuracy, whereas E is the expected accuracy based 
on the marginal totals of the confusion matrix (Kuhn 
& Johnson 2013). 
 
Structure and Sequence Conservation 
Visualization  
The crystal structure of ternary complex of TCR, 
influenza HA antigen peptide, and HLA-
DRB1*01:01 with a code 1FYT was retrieved from 
RCSB Protein Data Bank (Burley et al. 2018). The 
structure was visualized using Biovia Discovery 
Studio 2016 (Systèmes 2016). Meanwhile, sequence 
conservation of binding registers in data set was 
generated using WebLogo (Crooks et al. 2004). 
 
RESULTS AND DISCUSSIONS 
Screening of Descriptor Sets 
Previously, Chowell et al. (2015) analyzed 
biochemical properties among immunogenic and 
non-immunogenic CD8+ peptides related to HLA-
A2. They observed hydrophobicity differences at 
specific TCR contact residues P4, P6, P7, and P8. 
Using the hydrophobicity property, they built a 
neural network model to complement the IEDB 
approach in predicting immunogenic CTL epitopes. 
Khan and Ranganathan (2011) proposed that the 
molecular surface electrostatic potential (MSEP) 
contributes in pMHC recognition by TCR. Zhang et 
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al. (2015) applied various combination of 
physicochemical descriptors to distinguish 
immunogenic and non-immunogenic CTL epitopes. 
In the case of HTL epitopes related to HLA-
DRB1*01:01, we evaluated hydrophobicity, steric, 
and electrostatic properties in a VHSE descriptor set 
(Mei et al. 2005) to build an immunogenic epitope 
prediction model. The VHSE is derived from 
experimental physicochemical properties of amino 
acids in an AAindex (Kawashima et al. 2008). 
 
Feature Selection 
Extraction of VHSE from binding register data 
resulted in 72 descriptors. These descriptors explain 
binding register residues in terms of hydrophobicity, 
steric, and electrostatic properties. During the antigen 
recognition event, only particular residues at the 
binding register interact with complementarity 
determining regions (CDRs) of a TCR (Sant’Angelo 
et al. 2002). Some residues at binding register might 
be more contribute in hydrophobicity, whereas others 
could participate through different physicochemical 
properties such as electrostatic or even do not interact 
with the TCR. Involving inappropriate properties, as 
descriptors, in predictive modelling may be 
redundant and decrease model performance (Kuhn & 
Johnson 2013; Guyon et al. 2006). Hence, we 
performed feature selection steps on the extracted 
descriptors to choose only the important ones. 
Using a selection by filter (SBF) method, we 
screened important descriptors from the binding-
register-extracted VHSE. The method evaluates the 
relevance of the predictors outside of the predictive 
models using univariate statistics (Kuhn & Johnson 
2013). In this work, we used analysis of variance 
(ANOVA) score. The SBF method retains twelve 
descriptors (SBF1). Subjecting these descriptors to a 
random forest training increase the ROC to 0.701 
(Table 1). The selected descriptors also increased the 
specificity (0.330), the precision/PPV (0.808), the 
Kappa (0.266), and the MCC (0.284), whereas the F1 
(0.854) is unchanged. 
We also carried out another feature selection, a 
recursive feature elimination (RFE) (Guyon et al. 
2006). It is a backward selection algorithm that 
prevents refitting models at every search step. Its 
implementation in the caret package incorporates 
resampling to obtain performance estimates with 
variation due to feature selection (Kuhn & Johnson 
2013). The use of the RFE method on the VHSE 
descriptors generated 15 descriptors (RFE1). 
Training these descriptors to a random forest 
algorithm increase the ROC to 0.723 (Table 1). The 
other increased performance metrics are the 
specificity (0.262), the precision/PPV (0.799), the 
Kappa (0.249), the F1 (0.865), and the MCC (0.299).  
Separately, we applied a collinearity removal 
procedure to the extracted VHSE descriptors. This 
procedure retained 55 collinearity-free descriptors. 
Further SBF method selected 8 descriptors (SBF2). 
These descriptors increased the ROC to 0.663 (Table 
1). In addition, they also increased Specificity 
(0.263), Precision/PPV (0.789), Kappa (0.170), F1 
(0.836), and MCC (0.182). 
With prior collinearity removal, recursive feature 
elimination retained 25 descriptors (RFE2). The use 
of the RFE2 increased the ROC to 0.727 (Table 1). 
The selected descriptors also increased Specificity 
(0.190), Precision/PPV (0.788), Kappa (0.209), F1 
(0.870), and MCC (0.289). 
The Figure 1 compares the performance of HTL 
epitope predictive models trained using different 
selected VHSE descriptors. The RFE2, VHSE 
descriptors selected by RFE method after collinearity 
removal, generated a model with the best average 
ROC performance (0.727). Thus, we selected the 
RFE2 for further modelling. 
 
Table 1. Average performance metrics of different feature selection methods on the VHSE descriptor set. These 
metrics were estimated through a resampling of a ten-repeated ten-fold cross-validation during a random forest 
training. 
 
 
ROC 
Sensitivity/ 
Recall 
Specificity 
Precision/ 
PPV 
F1 Kappa MCC 
Full VHSE 0.672 0.954 0.144 0.775 0.854 0.124 0.176 
SBF1 0.701 0.907 0.330 0.808 0.854 0.266 0.284 
RFE1 0.723 0.946 0.262 0.799 0.865 0.249 0.299 
SBF2 0.663 0.891 0.263 0.789 0.836 0.170 0.182 
RFE2 0.727 0.973 0.190 0.788 0.870 0.209 0.289 
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Figure 1. Average performance metrics of different feature selection methods on the VHSE descriptor set. 
 
Table 2. Performance metrics of three sub-models and probabilities average model trained using the best 
selected VHSE descriptors. 
 
Model ROC Sensitivity/ 
Recall 
Specificity Precision/ 
PPV 
F1 Kappa MCC 
Sub-model1 0.664 0.671 0.550 0.850 0.750 0.171 0.185 
Sub-model2 0.616 0.724 0.500 0.846 0.786 0.186 0.194 
Sub-model3 0.692 0.658 0.600 0.862 0.746 0.194 0.214 
Ensemble 0.661 0.724 0.600 0.873 0.791 0.261 0.277 
Optimized probability threshold 0.672 0.750 0.600 0.877 0.809 0.291 0.304 
 
 
Probability Average and Probability Threshold 
Optimization 
The binding register data set contains an 
imbalance class where the immunogenic is three 
times of the non-immunogenic in number. To balance 
the data in the training set, we split the immunogenic 
into three different sub-groups and added all non-
immunogenic data. Hence, each sub-group has 
different immunogenic data but same non-
immunogenic ones. 
We used the best selected VHSE descriptors 
(RFE2) in each sub-group to train three random 
forest sub-models. Averaging probabilities of all sub-
models gave the ROC of 0.661, the sensitivity of 
0.724, and the specificity of 0.600. The majority 
performance metrics of the average model are 
superior to those of the sub-models (see Table 2). 
To handle the class imbalance issue, we also 
carried out another approach. We optimized 
probability threshold to get an appropriate balance 
between sensitivity and specificity. Such 
optimization tunes the model using a resampling 
procedure; hence no additional data set is required. 
Interestingly, it also automatically applies the 
optimized probability threshold in predicting unseen 
data. The threshold probability threshold procedure 
exhibits better performance metrics than the 
ensemble one, except for the specificity (Table 2). Its 
ROC is 0.672, whereas the sensitivity is 0.750. 
 
Analysis of Position-Based VHSE Descriptors 
To elucidate the important residue positions as 
well as the related physicochemical properties within 
the peptide binding register interacting with the TCR, 
we performed a Wilcoxon rank-sum test. The test 
result (Table 3) indicates statistical differences 
between the VHSE at binding registers of 
immunogenic and non-immunogenic. It suggests that 
the majority of important residues located at the 
center of the binding register.  
The Table 3 indicates statistical differences 
between immunogenic and non-immunogenic peptide 
binding registers at positions P3, P4, P5, and P6. At 
these four positions, the hydrophobic principal scores 
(VHSE1 and 2) show statistical differences between 
immunogenic and non-immunogenic peptides. The 
immunogenic peptides have lover average VHSE1 
scores at P5 (p = 2.82×10-2) than the non-
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Table 3. Residue-by-residue analysis of each VHSE descriptor vector between immunogenic and non-
immunogenic HTL peptides at their binding registers. The analysis was determined by using the Wilcoxon rank-
sum test. 
 
 P1 P2 P3 P4 P5 P6 P7 P8 P9 
VHSE1 8.10×10-1 3.68×10-1 5.46×10-1 7.60×10-1 2.82×10-2 8.79×10-1 7.97×10-1 7.20×10-1 6.70×10-1 
VHSE2 7.13×10-1 7.58×10-1 3.07×10-2 8.89×10-3 2.42×10-1 4.89×10-4 5.43×10-1 7.81×10-1 1.56×10-1 
VHSE3 4.35×10-1 9.94×10-1 5.52×10-2 9.20×10-2 3.30×10-1 6.61×10-4 6.46×10-1 8.81×10-1 5.75×10-1 
VHSE4 6.28×10-1 6.46×10-1 2.93×10-2 9.58×10-1 6.45×10-3 7.65×10-2 6.01×10-1 1.16×10-1 3.14×10-1 
VHSE5 3.09×10-1 5.85×10-1 1.35×10-1 6.88×10-1 5.58×10-1 1.33×10-1 7.30×10-1 6.98×10-1 9.69×10-1 
VHSE6 8.33×10-1 7.00×10-1 4.78×10-2 5.02×10-1 2.50×10-2 5.83×10-2 9.33×10-1 7.42×10-1 1.93×10-1 
VHSE7 6.47×10-1 1.43×10-1 7.77×10-1 1.76×10-1 2.03×10-1 1.28×10-2 8.94×10-1 1.55×10-1 4.05×10-1 
VHSE8 7.79×10-1 5.73×10-1 6.20×10-1 4.90×10-1 6.26×10-2 4.30×10-2 8.34×10-1 5.39×10-1 2.35×10-1 
 
 
 
 
Figure 2. Comparison of average of VHSE scores representing hydrophobic properties between immunogenic 
and non-immunogenic at binding registers. The green, turquoise, and purple lines indicates the non-
immunogenic peptides, whereas the red line is the immunogenic ones. 
 
 
 
Figure 3. Comparison of average of VHSE scores representing steric properties between immunogenic and non-
immunogenic at binding registers. The green, turquoise, and purple lines indicate the non-immunogenic 
peptides, whereas the red line is the immunogenic ones. 
 
 
immunogenic ones (Figure 2). For the VHSE2, the 
average scores of immunogenic peptides are higher at 
P3 (p = 3.07×10-2) and P4 (p = 8.89×10-3), but they 
are lower at P6 (p = 4.89×10-4). 
The importance of residues at middle positions is 
also exhibited by steric principal scores, the VHSE3 
and 4. The average VHSE3 scores of immunogenic 
peptides are higher than that of non-immunogenic 
ones at P6 (p = 6.61×10-4) (Figure 3). In contrast, the 
immunogenic peptides have lower average VHSE4 
scores at P3 (p = 2.93×10-2) and P5 (p = 6.45×10-3). 
Of four electrostatic kind descriptors, three 
VHSEs (VHSE6, 7, and 8) show significant 
differences at middle positions of the binding 
register. At positions P3 and P5, average VHSE6 
scores of immunogenic peptides are higher than that 
of non-immunogenic ones (P3, p = 4.78×10-2; P5, p = 
2.50×10-2) (Figure 4). Both kinds of peptides also 
58 
 
 
Chimica et Natura Acta Vol. 7 No. 2, Agustus 2019: 51-62 
 
 
 
Figure 4. Comparison of average of VHSE scores representing electrostatic properties between immunogenic 
and non-immunogenic at binding registers. The green, turquoise, and purple lines indicate the non-immunogenic 
peptides, whereas the red line is the immunogenic ones. 
 
 
 
Figure 5. Interactions of a peptide epitope with residues of TCR in a crystal structure of ternary complex of TR, 
influenza HA antigen peptide, and HLA-DRB1*01:01 (1FYT). 
 
 
Immunogenic 
 
Non-immunogenic 
 
Figure 6. Sequence logos of immunogenic and non-immunogenic HTL epitopes. 
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have significantly different average VHSE7 and 8 
scores at P6. The immunogenic VHSE7 scores are 
lower at this position (p = 1.28×10-2), whereas the 
VHSE8 are lower (p = 4.30×10-2). 
The notion that important positions are at center 
of binding registers and the P8 is supported by a 
crystal structure of ternary complex of TR, influenza 
HA antigen peptide, and HLA-DRB1*01:01 (1FYT). 
This crystal structure shows that interactions occur on 
the peptide epitope at its center of binding register, at 
position P3, P5, P6, and P8. The residue at the 
position P3 (K310) forms a salt bridge interaction 
with E102 from the CDR3 of the TR, similarly the 
residue at P8 (K315) also interact through a salt 
bridge with D28 and E30 (CDR2) and a hydrogen 
bond with T98. However, unexpected hydrophobic 
interaction occurs at the P2. In addition, a hydrogen 
bond at flanking residue is also observed. 
The Figure 6 depicts sequence logos of 
immunogenic and non-immunogenic HTL epitopes. 
Despite having high similarity at the position P1 and 
resemblance at other anchor residues (P4, 6, and 9), 
the immunogenic HTL epitopes exhibit some 
differences with the non-immunogenic ones at 
positions P4 and P6. At the position P4, an acidic 
residue E is the second highest occurrence in 
immunogenic epitopes (10.59%), whereas it only has 
a probability 2.41% in non-immunogenic ones. 
Meanwhile at the position P6, the immunogenic 
epitopes have higher amino acid variation (17 
residues) than the non-immunogenic epitopes (12 
residues). They also have high occurrence of polar 
residues G (20.39%) and S (15.29%), whereas in 
non-immunogenic are 9.64% for G and 6.02% for S. 
Conversely, another polar residue, T, is 15.66% in 
the immunogenic. It is higher than the non-
immunogenic epitopes have (5.49%).  
Other differences are also observed on suggested 
important positions for peptide-epitopes-TCR 
interaction. The P5 in immunogenic show high 
probability of charge amino acids (K and E, 11.76 
and 8.63% respectively), whereas the non-
immunogenic are common with hydrophobic amino 
acids. At the position P8, slight differences are 
observed. For example, immunogenic has a high 
probability of K 14.51%, whereas the K 
immunogenic is 9.64%. 
 
CONCLUSIONS 
In this work, we screened amino acid descriptor 
sets extracted from the peptide binding registers for 
immunogenicity modelling of HTL epitopes. The 
best performance given by VHSE suggests that 
hydrophobic, steric, and electrostatic properties of 
amino acids at the peptide binding register are 
sufficient for immunogenic modelling of HTL 
epitopes. Combination of these physicochemical 
properties at the center of binding register –
particularly positions P3, 4, 5 and 6– and the positon 
P8 may play important role in the recognition of 
immunogenic HTL epitopes by the TCR.  
In this predictive modelling of immunogenic HTL 
epitopes, the effect of class imbalance was persistent 
issue to eliminate. To alleviate this negative effect, 
we found that the approach of probability threshold 
optimization approach is better than the probabilities 
average. 
Finally, we have developed a model for screening 
the immunogenic HTL epitopes from predicted 
peptide MHC-binders. The model helps to reduce 
non-immunogenic peptide MHC-binders from the 
result of two existing prediction webservers, 
NetMHCIIpan and TEPITOPEpan. Currently, the 
immunogenicity model is restricted to HLA-
DRB1*01:01. This human MHC allele is protective 
against developing multiple sclerosis and association 
with autoimmune diseases. Thus our model is able to 
assist a rational development of vaccines as well as 
immunotherapeutic agents related to those diseases. 
Furthermore, the methodology can be applied to 
develop predictive models of immunogenic HTL 
epitopes restricted to another human MHC alleles. 
 
ACKNOWLEDGEMENTS 
We acknowledge the Indonesia Endowment Fund 
scholarship to AH and Prof. Shoba Ranganathan 
from Macquarie University, Australia for her 
supervision. 
 
REFERENCES 
Andreatta, M., Karosiene, E., Rasmussen, M., Stryhn, 
A., Buus, S. & Nielsen, M. (2015) Accurate 
pan-specific prediction of peptide-MHC class II 
binding affinity with improved binding core 
identification. Immunogenetics. 67(11–12): 
641–650. 
Bordner, A.J. & Abagyan, R. (2006) Ab initio 
prediction of peptide-MHC binding geometry 
for diverse class I MHC allotypes. Protein: 
Structure, Function, and Bioinformatics. 63: 
512–526. 
Breiman, L. (2001) Random forests. Machine 
Learning. 45(1): 5–32. 
Burley, S.K., Berman, H.M., Bhikadiya, C., Bi, C., 
Chen, L., Di Costanzo, L., Christie, C., 
Dalenberg, K., Duarte, J.M., Dutta, S., Feng, Z., 
Ghosh, S., Goodsell, D.S., Green, R.K., 
Guranović, V., Guzenko, D., Hudson, B.P., 
Kalro, T., Liang, Y., Lowe, R., Namkoong, H., 
Peisach, E., Periskova, I., Prlić, A., Randle, C., 
Rose, A., Rose, P., Sala, R., Sekharan, M., 
Shao, C., Tan, L., Tao, Y.-P., Valasatava, Y., 
Voigt, M., Westbrook, J., Woo, J., Yang, H., 
Young, J., Zhuravleva, M., & Zardecki, C. 
(2018) RCSB Protein Data Bank: biological 
macromolecular structures enabling research 
and education in fundamental biology, 
biomedicine, biotechnology and energy. 
Nucleic Acids Research. 47(D1): D464–D474. 
60 
 
 
Chimica et Natura Acta Vol. 7 No. 2, Agustus 2019: 51-62 
 
Chowell, D., Krishna, S., Becker, P.D., Cocita, C., 
Shu, J., Tan, X., Greenberg, P.D., Klavinskis, 
L.S., Blattman, J.N., & Anderson, K.S. (2015) 
TCR contact residue hydrophobicity is a 
hallmark of immunogenic CD8 + T cell 
epitopes. Proceedings of the National Academy 
of Sciences. 112(14): E1754–E1762. 
Chuan, T.J. & Ranganathan, S. (2013) Computer-
aided vaccine design. Woodhead Publishing. 
Crooks, G., Hon, G., Chandonia, J., & Brenner, S. 
(2004) WebLogo: a sequence logo generator. 
Genome Research. 14: 1188–1190. 
Gilboa, E. (2016) A quantum leap in cancer 
vaccines ? Journal for ImmunoTherapy of 
Cancer, 4: 87. 
Gonzalez-Galarza, F.F., Christmas, S., Middleton, D., 
& Jones, A.R. (2011) Allele frequency net: A 
database and online repository for immune gene 
frequencies in worldwide populations. Nucleic 
Acids Research. 39(Supplement 1): 913–919. 
Goyette, P., Boucher, G., Mallon, D., Ellinghaus, E., 
Jostins, L., Huang, H., Ripke, S., Gusareva, 
E.S., Annese, V., Hauser, S.L., Oksenberg, J.R., 
Thomsen, I., Leslie, S., Abraham, C., Achkar, 
J.-P., Ahmad, T., Amininejad, L., 
Ananthakrishnan, A.N., Andersen, V., 
Anderson, C.A, Andrews, J.M., Annese, V., 
Aumais, G., Baidoo, L., Baldassano, R.N., 
Balschun, T., Bampton, P.A, Barclay, M., 
Barrett, J.C., Bayless, T.M., Bethge, J., Bis, 
J.C., Bitton, A., Boucher, G., Brand, S., Brant, 
S.R., Büning, C., Chew, A., Cho, J.H., Cleynen, 
I., Cohain, A., Croft, A., Daly, M.J., D′Amato, 
M., Danese, S., De Jong, D., De Vos, M., 
Denapiene, G., Denson, L. a, Devaney, K.L., 
Dewit, O., D′Inca, R., Dubinsky, M., Duerr, 
R.H., Edwards, C., Ellinghaus, D., Essers, J., 
Ferguson, L.R., Festen, E. a, Fleshner, P., 
Florin, T., Franchimont, D., Franke, A., 
Fransen, K., Gearry, R., Georges, M., Gieger, 
C., Glas, J., Goyette, P., Green, T., Griffiths, 
A.M., Guthery, S.L., Hakonarson, H., 
Halfvarson, J., Hanigan, K., Haritunians, T., 
Hart, A., Hawkey, C., Hayward, N.K., Hedl, 
M., Henderson, P., Hu, X., Huang, H., Hui, 
K.Y., Imielinski, M., Ippoliti, A., Jonaitis, L., 
Jostins, L., Karlsen, T.H., Kennedy, N. a, Khan, 
M.A., Kiudelis, G., Kugathasan, S., 
Kupcinskas, L., Latiano, A., Laukens, D., 
Lawrance, I.C., Lee, J.C., Lees, C.W., Leja, M., 
Van Limbergen, J., Lionetti, P., Liu, J.Z., 
Louis, E., Mahy, G., Mansfield, J., Massey, D., 
Mathew, C.G., McGovern, D.P.B., Milgrom, 
R., Mitrovic, M., Montgomery, G.W., Mowat, 
C., Newman, W., Ng, A., Ng, S.C., Ng, S.M.E., 
Nikolaus, S., Ning, K., Nöthen, M., 
Oikonomou, I., Palmieri, O., Parkes, M., 
Phillips, A., Ponsioen, C.Y., Potocnik, U., 
Prescott, N.J., Proctor, D.D., Radford-Smith, 
G., Rahier, J.-F., Raychaudhuri, S., Regueiro, 
M., Rieder, F., Rioux, J.D., Ripke, S., Roberts, 
R., Russell, R.K., Sanderson, J.D., Sans, M., 
Satsangi, J., Schadt, E.E., Schreiber, S., 
Schumm, L.P., Scott, R., Seielstad, M., Sharma, 
Y., Silverberg, M.S., Simms, L. a, 
Skieceviciene, J., Spain, S.L., Steinhart,  a H., 
Stempak, J.M., Stronati, L., Sventoraityte, J., 
Targan, S.R., Taylor, K.M., Velde, A. Ter, 
Theatre, E., Torkvist, L., Tremelling, M., van 
der Meulen, A., van Sommeren, S., 
Vasiliauskas, E., Vermeire, S., Verspaget, 
H.W., Walters, T., Wang, K., Wang, M.-H., 
Weersma, R.K., Wei, Z., Whiteman, D., 
Wijmenga, C., Wilson, D.C., Winkelmann, J., 
Xavier, R.J., Zeissig, S., Zhang, B., Zhang, 
C.K., Zhang, H., Zhang, W., Zhao, H., Zhao, 
Z.Z., Daly, M.J., Van Steen, K., Duerr, R.H., 
Barrett, J.C., McGovern, D.P.B., Schumm, 
L.P., Traherne, J.A., Carrington, M.N., 
Kosmoliaptsis, V., Karlsen, T.H., Franke, A., & 
Rioux, J.D. (2015) High-density mapping of the 
MHC identifies a shared role for HLA-
DRB1*01:03 in inflammatory bowel diseases 
and heterozygous advantage in ulcerative 
colitis. Nature Genetics. 47(2): 172–179. 
Guan, P., Doytchinova, I.A., Zygouri, C., & Flower, 
D.R. (2003) MHCPred: a server for quantitative 
prediction of peptide–MHC binding. Nucleic 
Acids Research . 31(13): 3621–3624. 
Guyon, I., Gunn, S., Nikravesh, M., & Zadeh, L.A. 
(2006) Feature Extraction: Foundations and 
Applications. I. Guyon, S. Gunn, M. Nikravesh, 
& L. A. Zadeh, eds. Springer, Berlin.  
Karosiene, E., Rasmussen, M., Blicher, T., Lund, O., 
Buus, S. & Nielsen, M. (2013) NetMHCIIpan-
3.0, a common pan-specific MHC class II 
prediction method including all three human 
MHC class II isotypes, HLA-DR, HLA-DP and 
HLA-DQ. Immunogenetics. 65(10): 711–724. 
Kawashima, S., Pokarowski, P., Pokarowska, M., 
Kolinski, A., Katayama, T., & Kanehisa, M. 
(2008) AAindex: Amino acid index database, 
progress report 2008. Nucleic Acids Research. 
36(Supplement 1): 202–205. 
Khan, J.M. & Ranganathan, S. (2010) pDOCK: A 
new technique for rapid and accurate docking 
of peptide ligands to Major Histocompatibility 
Complexes. Immunome Research. 
6(Supplement 1): S2. 
Khan, J.M. & Ranganathan, S. (2011) Understanding 
TR binding to pMHC complexes: How does a 
TR scan many pMHC complexes yet 
preferentially bind to one. PloS One. 6(2): 
e17194. 
Kuhn, M. (2008) Building predictive models in R 
using the caret package. Journal Of Statistical 
Software. 28(5): 1–26. 
Kuhn, M. & Johnson, K. (2013) Applied Predictive 
Modeling. Springer, New York. 
Kuhn, M., Wing, J., Weston, S., Williams, A., 
61 
 
 
Development of Predictive Model for Helper T Lymphocyte Epitope Binding to HLA-DRB1*01:01 
Hardianto, A., Yusuf, M.  
 
Keefer, C., Engelhardt, A., Cooper, T., Mayer, 
Z., Kenkel, B., Benesty, M., Lescarbeau, R., 
Ziem, A., Scrucca, L., Tang, Y., & Candan., C. 
(2016) Caret: Classification and regression 
training. Astrophysics Source Code Library. 
Lerner, A., Jeremias, P. & Matthias, T. (2015) The 
World Incidence and Prevalence of 
Autoimmune Diseases is Increasing. 
International Journal of Celiac Disease. 3(4): 
151–155. 
Mei, H., Liao, Z.H., Zhou, Y. & Li, S.Z. (2005) A 
new set of amino acid descriptors and its 
application in peptide QSARs. Biopolymers. 
80(6): 775–86. 
Murphy, K. (2011) Janeway’s Immunobiology. 8th ed. 
Garland Science. London. 
Nielsen, M., Lundegaard, C., Worning, P., Hvid, 
C.S., Lamberth, K., Buus, S., Brunak, S. & 
Lund, O. (2004) Improved prediction of MHC 
class I and class II epitopes using a novel Gibbs 
sampling approach. Bioinformatics. 20(9): 
1388–1397. 
Oyarzún, P. & Kobe, B. (2016) Recombinant and 
epitope-based vaccines on the road to the 
market and implications for vaccine design and 
production. Human Vaccines & 
Immunotherapeutics. 12(3): 763–767. 
Patronov, A., Dimitrov, I., Flower, D.R. & 
Doytchinova, I. (2011) Peptide binding 
prediction for the human class II MHC allele 
HLA-DP2: a molecular docking approach. 
BMC Structural Biology. 11(1): 32. 
Peters, B., Bui, H.H., Frankild, S., Nielsen, M., 
Lundegaard, C., Kostem, E., Basch, D., 
Lamberth, K., Harndahl, M., Fleri, W., Wilson, 
S.S., Sidney, J., Lund, O., Buus, S. & Sette, A. 
(2006) A community resource benchmarking 
predictions of peptide binding to MHC-I 
molecules. PLoS Computational Biology. 2(6): 
0574–0584. 
R Core Team (2015) R: A language and environment 
for statistical computing. R Foundation for 
Statistical Computing. Vienna, Austria. 
Rammensee, H.-G., Bachmann, J., Emmerich, 
N.P.N., Bachor, O.A. & Stevanović, S. (1999) 
SYFPEITHI: database for MHC ligands and 
peptide motifs. Immunogenetics. 50(3–4): 213–
219. 
Reche, P.A, Glutting, J.-P., Zhang, H. & Reinherz, 
E.L. (2004) Enhancement to the RANKPEP 
resource for the prediction of peptide binding to 
MHC molecules using profiles. 
Immunogenetics. 56(6): 405–419. 
Rognan, D., Scapozza, L., Folkers, G., & Daser, A. 
(1994) Molecular dynamics simulation of 
MHC-peptide complexes as a tool for 
predicting potential T cell epitopes. 
Biochemistry. 33(38): 11476–11485. 
Rosenfeld, R., Zheng, Q., Vajda, S. & DeLisi, C. 
(1995) Flexible docking of peptides to class I 
major-histocompatibility-complex receptors. 
Genetic Analysis: Biomolecular Engineering. 
12(1): 1–21. 
Saethang, T., Hirose, O., Kimkong, I., Tran, V.A., 
Dang, X.T., Nguyen, L.A.T., Le, T.K.T., Kubo, 
M., Yamada, Y. & Satou, K. (2013) PAAQD: 
Predicting immunogenicity of MHC class I 
binding peptides using amino acid pairwise 
contact potentials and quantum topological 
molecular similarity descriptors. Journal of 
Immunological Methods. 387(1–2): 293–302. 
Sant’Angelo, D.B., Robinson, E., Janeway, C.A. & 
Denzin, L.K. (2002) Recognition of core and 
flanking amino acids of MHC class II-bound 
peptides by the T cell receptor. European 
Journal of Immunology. 32(9): 2510–2520. 
Sauer, E.L., Cloake, N.C., & Greer, J.M. (2015) 
Taming the TCR: Antigen-specific 
immunotherapeutic agents for autoimmune 
diseases. International Reviews of Immunology. 
34(6): 460-485. 
Systèmes, D. (2016) Dassault Systèmes BIOVIA, 
Discovery Studio Modeling Environment, 
Release 2016. 
Tong, J.C., Tan, T.W., & Ranganathan, S. (2007) In 
silico grouping of peptide/HLA class I 
complexes using structural interaction 
characteristics. Bioinformatics (Oxford, 
England). 23(2): 177–183. 
Tong, J.C., Tan, T.W., & Ranganathan, S. (2004) 
Modeling the structure of bound peptide ligands 
to major histocompatibility complex. Protein 
Science. 13(9): 2523–2532. 
Tung, C.-W., Ziehm, M., Kämper, A., Kohlbacher, 
O. & Ho, S.-Y. (2011) POPISK: T-cell 
reactivity prediction using support vector 
machines and string kernels. BMC 
Bioinformatics. 12(1): 446. 
Vita, R., Mahajan, S., Overton, J.A., Dhanda, S.K., 
Martini, S., Cantrell, J.R., Wheeler, D.K., Sette, 
A. & Peters, B. (2018) The Immune Epitope 
Database (IEDB): 2018 update. Nucleic Acids 
Research. 47(D1), D339–D343. 
van Westen, G.J., Swier, R.F., Wegner, J.K., 
Ijzerman, A.P., van Vlijmen, H.W. & Bender, 
A. (2013) Benchmarking of protein descriptor 
sets in proteochemometric modeling (part 1): 
comparative study of 13 amino acid descriptor 
sets. Journal of Cheminformatics. 5(1): 41. 
WHO. 2017. Global Health Estimates 2016 
Summary. 
https://www.who.int/healthinfo/global_burden_
disease/ 
GHE2016_YLD_WBI_2000_2016_.xls 
Zhang, G.L., Khan, A.M., Srinivasan, K.N., August, 
J.T. & Brusic, V. (2005) MULTIPRED: A 
computational system for prediction of 
promiscuous HLA binding peptides. Nucleic 
Acids Research. 33(SUPPL. 2): 172–179. 
Zhang, L., Chen, Y., Wong, H.-S., Zhou, S., 
62 
 
 
Chimica et Natura Acta Vol. 7 No. 2, Agustus 2019: 51-62 
 
Mamitsuka, H. & Zhu, S. (2012) 
TEPITOPEpan: extending TEPITOPE for 
peptide binding prediction covering over 700 
HLA-DR molecules. PloS one. 7(2): e30483. 
Zhang, W., Niu, Y., Zou, H., Luo, L., Liu, Q. & Wu, 
W. (2015) Accurate prediction of immunogenic 
T-cell epitopes from epitope sequences using 
the genetic algorithm-based ensemble learning. 
Plos One. 10(5): e0128194. 
 
